Pyridoclax
CAS No. 1651890-44-6
Pyridoclax ( MR-29072 )
Catalog No. M12523 CAS No. 1651890-44-6
Pyridoclax (MR29072) is a highly potent Mcl-1 inhibitor with Kd of 25 nM, disrupts Mcl-1/Bim interaction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePyridoclax
-
NoteResearch use only, not for human use.
-
Brief DescriptionPyridoclax (MR29072) is a highly potent Mcl-1 inhibitor with Kd of 25 nM, disrupts Mcl-1/Bim interaction.
-
DescriptionPyridoclax (MR29072) is a highly potent Mcl-1 inhibitor with Kd of 25 nM, disrupts Mcl-1/Bim interaction; strongly sensitizes ovarian cancer chemoresistant IGROV1-R10 cells to Bcl-xL targeting siRNA and ABT-737, leading to massive apoptosis, can not induce cell death as single agents; induces ER stress and modifies Bcl-2 family expression, but its cytotoxic effect does not require these events.
-
SynonymsMR-29072
-
PathwayAngiogenesis
-
TargetBcl-2
-
RecptorBcl-2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1651890-44-6
-
Formula Weight426.51
-
Molecular FormulaC29H22N4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC1=CC(C2=NC=C(C3=CC=CN=C3)C=C2/C=C/C4=CC=CC=C4)=CN=C1C5=CC=CN=C5
-
Chemical Name(E)-3'-methyl-3''-styryl-3,2':5',2'':5'',3'''-quaterpyridine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gloaguen C, et al. J Med Chem. 2015 Feb 26;58(4):1644-68.
2. Groo AC, et al. Eur J Pharm Sci. 2017 Jan 15;97:218-226.
2. Groo AC, et al. Eur J Pharm Sci. 2017 Jan 15;97:218-226.
molnova catalog
related products
-
Obatoclax
A potent inhibitor of Bcl-2 family with IC50s of 1-7 uM for Bcl-2, Bcl-XL, Bcl-w, Bcl-B, Mcl-1 and Bfl-1.
-
VU661013
VU661013 (VU-661013) is a novel potent, selective MCL-1 inhibitor with Ki of 97 pM (human MCL-1) in TR-FRET assay.
-
S55746 hydrochloride
S55746 (BCL201, Servier-1) is a novel potent, selective, orally bioavailable inhibitor of BCL-2 with Ki of 1.3 nM.